References
- Agarwal M K, Jhamb S. Immunodiagnosis of Type I respiratory allergic disorders. Cardiothoracic J 1995; 1(6)36–50
- Estelle F, Simons R. Antihistamines. Allergy Principles and Practice, E Middleton, Jr., C E Reed, E F Ellis, N F Adkinson, J W Yunginger, W W Busse. Mosby, St. Louis, MO 1998; 612–637
- Chhabra S K, Singh P, Jhamb S, Agarwal M K. Duration of inhibitory effect of terfernadine on histamine-induced skin wheals. Ann Allergy Asthma Immunol 1996; 76: 373–375
- Kilinc I, Alper S. Adverse effects of antihistamines on skin tests and antihistamines in pregnancy. Curr Med Chem-Anti-Inflammatory Anti-Allergy Agents 2005; 4: 517–519
- Long W F, Taylor R J, Wagner C J, et al. Skin test suppression by antihistamines and the development of subsensitivity. J Allergy Clin Immunol 1985; 76: 113–117
- Cook T J, MacQueen D M, Wittig H J, et al. Degree and duration of skin test suppression and side effects with antihistamines: a double blind controlled study with five antihistamines. J Allergy Clin Immunol 1973; 51: 71–77
- Simons F E, McMillan J L, Simons K J. Double–blind single-dose, crossover comparison of cetrizine, terfenadine, loratadine, astemizole and chlorpheniramine versus placebo: suppressive effects on histamine induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990; 86: 540–547
- Perhach J L, Chand N, Diamantis W, Sofia R D, Rosenberg A. Azelastine—a novel oral antiasthma compound with several modes of action. Allergy and Asthma. New trends and approaches to therapy, A B Kay. Blackwell Scientific Publications, Oxford 1989; 230–248
- Ciprandi G, Ricca V, Passalacqua G, et al. Seasonal rhinitis and azelastine: Long-or short-term treatment?. J Allergy Clin Immunol 1997; 99: 301–307
- Con de Hernandez D J, Palma Aqilar J L, Delgado Romero J. Comparison of azelastine nasal spray and oral ebastine in treating seasonal allergic rhinitis. Curr Med Res Opin 1995; 13(6)299–304
- Davies R J, Bagnall A C, McCabe R N, Calderon M A, Wang J H. Antihistamines: topical vs oral administration. Clin Exp Allergy 1996; 26(3)11–17
- Lumry W, Prenner B, Corren J, Wheeler W. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily. Ann Allergy Asthma Immunol 2007; 99: 267–272
- Atkins P, Merton H, Karin P, et al. Azelastine inhibition of skin test reactivity in humans. J Allergy Clin Immunol 1985; 75: 167, (Abstract)
- De Weck A L, Derer T, Bahre M. Investigation of the anti-allergic activity of azelastine on the immediate and late-phase reactions to allergens and histamine using telethermography. Clin Exp Allergy 2000; 30(2)283–287
- Kausar M A, Vijayan V K, Bansal S K, Menon B K, Vermani M, Agarwal M K. Mosquitoes as sources of inhalant allergens: Clinicoimmunologic and biochemical studies. J Allergy Clin Immunol 2007; 120(5)1219–1221
- Agarwal M K. Skin testing and respiratory allergic disorders [guest editorial]. Ind J Chest Dis 1986; 28: 179–182
- Agarwal M K, Gaur S N, Chaudhry S. Effect of prior medication on intradermal test response in patients with respiratory allergies. J Asthma 1988; 25(5)275–279
- Pearlman D S, Grossman J, Meltzer E O. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003; 91: 258–262